Cyclophosphamide

Formula : C7-H15-Cl2-N2-O2-P
CAS : 50-18-0 
B 518 4-27-00-09750 (Beilstein Handbook Reference) AI3-26198 ASTA B518 N|N-Bis-(beta-chloraethyl)-N'|O-propylen-phosphorsaeure-ester-diamid [German] 2-(Bis(2-chloroethyl)amino)-2H-1|3|2-oxazaphosphorine 2-oxide 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin 2-(Bis(2-chloroethyl)amino)tetrahydro-2H-1|3|2-oxazophosphorine 2-oxide Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester N|N-Bis(beta-chloroethyl)-N'|O-propylenephosphoric acid ester diamide N|N-Bis(2-chloroethyl)-N'|O-propylenephosphoric acid ester diamide N|N-Bis(2-chloroethyl)tetrahydro-2H-1|3|2-oxazaphosphorin-2-amine 2-oxide N|N-Bis(beta-chloroethyl)-N'|O-trimethylenephosphoric acid ester diamide BRN 0011744 CB 4564 CCRIS 188 Ciclofosfamida [INN-Spanish] Clafen Claphene Cyclophosphamid Cyclophosphamide Cyclophosphamidum Cyclophosphamidum [INN-Latin] Cyclophosphan Cyclophosphane Cyclophosphanum Cyclophosphoramide Cyclostin Cyklofosfamid [Czech] Cytophosphan Cytophosphane Cytoxan N|N-Di(2-chloroethyl)-N|O-propylene-phosphoric acid ester diamide EINECS 200-015-4 Endoxan Endoxan R Endoxana Endoxanal Endoxan-asta Genoxal HSDB 3047 4-Hydroxy-cyclophosphan-mamophosphatide NCI-C04900 Occupation| cyclophosphamide exposure Phosphorodiamidic acid| N|N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-| intramol. ester Procytox RCRA waste number U058 Sendoxan SK 20501 Zyklophosphamid [German] (+-)-Cyclophosphamide (RS)-Cyclophosphamide NSC 26271 Ciclophosphamide Ciclophosphamide [INN] Lyophilized cytoxan Neosar Ciclofosfamida Cyklofosfamid N|N-Bis-(beta-chloraethyl)-N'|O-propylen-phosphorsaeure-ester-diamid Zyklophosphamid UNII-6UXW23996M NSC-26271 D|L-Cyclophosphamide

Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active ALDOPHOSPHAMIDE. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.

Cyclophosphamide

Formula : C7-H15-Cl2-N2-O2-P.H2-O
CAS : 6055-19-2 

Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.

Cyclophosphamide regimen with epirubicin and fluorouracil

Formula :

Chemotherapy protocol consisting of fluorouracil, epirubicin & cyclophosphamide.

NCI: A chemotherapy regimen consisting of fluorouracil, epirubicin and cyclophosphamide used in the adjuvant setting for the primary treatment of breast cancer. This regimen is also used for the treatment of recurrent and metastatic breast cancer. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Cyclophosphamide regimen with Fluorouracil and Methotrexate

Formula :

NCI: A chemotherapy regimen consisting of cyclophosphamide, methotrexate, and fluorouracil, which may be used in the adjuvant setting for the treatment of nonmetastatic breast cancer or alone for the treatment of metastatic breast cancer. (NCI Thesaurus)

Cyclophosphamide regimen with Prednisone, Procarbazine and Vincristine

Formula :

Chemotherapy protocol consisting of ... /four/ cpds; used in treatment for Hodgkins disease

NCI: A chemotherapy regimen consisting of cyclophosphamide, vincristine (Oncovin), procarbazine and prednisone used for the treatment of Hodgkin and non-Hodgkin lymphoma. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)